Tag Archive | "Boehringer Ingelheim"

Zealand Pharma and Boehringer Ingelheim sign a pharma licensing deal

Tags: , , ,


Zealand Pharma and Boehringer Ingelheim announced a new global exclusive pharma licensing, research and development collaboration for $402 million.  Read the full story

Boehringer Ingelheim pays a settlement fee of $650 million

Tags: ,


Boehringer Ingelheim has agreed to pay $650 million to wrap up thousands of lawsuits claiming Pradaxa, an anticoagulant, caused serious--even fatal--bleeding in some patients. Read the full story

Top 50 Pharma (top pharmaceutical companies)

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,


The term 'top pharma' can relate to the top pharmaceutical companies or the top 10 or 50... Read the full story

Boehringer Ingelheim partnering

Tags: ,


Boehringer Ingelheim is a top pharmaceutical company based in Ingelheim, Germany Read the full story

Collaboration agreement to initiate multi-center idiopathic pulmonary fibrosis registry and biomarker bank

Tags: , ,


Boehringer Ingelheim Pharmaceuticals and Duke Clinical Research Institute have formed a unique collaborative relationship to uncover insights into idiopathic pulmonary fibrosis. Read the full story

BioFocus pharma alliances with Boehringer Ingelheim in drug discovery

Tags: , , ,


BioFocus pharma alliances with big pharma Boehringer Ingelheim signing a new collaboration agreement Read the full story

Beactica expands pharma business development with Boehringer Ingelheim

Tags: , ,


Beactica has expanded its pharma business development collaboration with Boehringer Ingelheim. a big pharma company. Read the full story

Boehringer Ingelheim signs biotech deals with Ventana for oncology programs

Tags: , , , ,


Ventana Medical Systems have signed biotech deals to collaborate on the development of companion diagnostic tests for Boehringer Ingelheim oncology programs Read the full story

Diaxonhit seals biotech deals with Boehringer Ingelheim for oncology targets

Tags: , , , ,


Diaxonhit forms biotech deals by entering into a research service agreement with big pharma Boehringer Ingelheim for the discovery and characterization of novel splice variants that have the potential to be therapeutic targets for oncology Read the full story

Boehringer Ingelheim pharma partners Brigham and Women’s Hospital

Tags: , , ,


Boehringer Ingelheim announced a multi-year pharma partners agreement with Brigham and Women's Hospital. Read the full story